196 related articles for article (PubMed ID: 27799525)
1. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.
Carroll VA; Lafferty MK; Marchionni L; Bryant JL; Gallo RC; Garzino-Demo A
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13168-13173. PubMed ID: 27799525
[TBL] [Abstract][Full Text] [Related]
2. Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
Dolcetti R; Giagulli C; He W; Selleri M; Caccuri F; Eyzaguirre LM; Mazzuca P; Corbellini S; Campilongo F; Marsico S; Giombini E; Muraro E; Rozera G; De Paoli P; Carbone A; Capobianchi MR; Ippolito G; Fiorentini S; Blattner WA; Lu W; Gallo RC; Caruso A
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14331-6. PubMed ID: 26578780
[TBL] [Abstract][Full Text] [Related]
3. Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient.
Caccuri F; Muraro E; Gloghini A; Turriziani O; Riminucci M; Giagulli C; Mastorci K; Fae' DA; Fiorentini S; Caruso A; Carbone A; Dolcetti R
Hematol Oncol; 2019 Apr; 37(2):176-184. PubMed ID: 30261551
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
[TBL] [Abstract][Full Text] [Related]
5. A lymphomagenic role for HIV beyond immune suppression?
Dolcetti R; Gloghini A; Caruso A; Carbone A
Blood; 2016 Mar; 127(11):1403-9. PubMed ID: 26773045
[TBL] [Abstract][Full Text] [Related]
6. In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma.
Selleri M; Dolcetti R; Caccuri F; Giombini E; Rozera G; Abbate I; Mammone A; Zanussi S; Martorelli D; Fiorentini S; Caruso A; Capobianchi MR
New Microbiol; 2017 Jan; 40(1):58-61. PubMed ID: 28072889
[TBL] [Abstract][Full Text] [Related]
7. Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.
Mazzuca P; Marsico S; Schulze K; Mitola S; Pils MC; Giagulli C; Guzman CA; Caruso A; Caccuri F
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592537
[TBL] [Abstract][Full Text] [Related]
8. B cell lymphoma in HIV transgenic mice.
Curreli S; Krishnan S; Reitz M; Lunardi-Iskandar Y; Lafferty MK; Garzino-Demo A; Zella D; Gallo RC; Bryant J
Retrovirology; 2013 Aug; 10():92. PubMed ID: 23985023
[TBL] [Abstract][Full Text] [Related]
9. The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.
Li S; Bozzo L; Wu Z; Lu W; Romerio F
New Microbiol; 2010 Jan; 33(1):13-24. PubMed ID: 20402410
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.
Giagulli C; D'Ursi P; He W; Zorzan S; Caccuri F; Varney K; Orro A; Marsico S; Otjacques B; Laudanna C; Milanesi L; Dolcetti R; Fiorentini S; Lu W; Caruso A
Sci Rep; 2017 Jul; 7(1):6555. PubMed ID: 28747658
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens.
Fiorentini S; Becker PD; Marini E; Marconi P; Avolio M; Tosti G; Link C; Manservigi R; Guzman CA; Caruso A
Viral Immunol; 2006; 19(2):177-88. PubMed ID: 16817760
[TBL] [Abstract][Full Text] [Related]
12. Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
Caccuri F; D'Ursi P; Uggeri M; Bugatti A; Mazzuca P; Zani A; Filippini F; Salmona M; Ribatti D; Slevin M; Orro A; Lu W; Liò P; Gallo RC; Caruso A
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372148
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms behind the generation of pro-oncogenic HIV-1 matrix protein p17 variants.
Zani A; Messali S; Bugatti A; Uggeri M; Rondina A; Sclavi L; Caccuri F; Caruso A
J Gen Virol; 2024 Apr; 105(4):. PubMed ID: 38687324
[TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
[TBL] [Abstract][Full Text] [Related]
15. High expression of HIV-1 matrix protein p17 in both lymphoma and lymph node tissues of AIDS patients.
Feng Y; Wang Z; Zeng D; Song S; Yang Y; Wang A; Xu J; Guo W; Wu M; Shi Y; Zheng Y; Li D; Zhang R; Lu H
Pathol Res Pract; 2022 Sep; 237():154061. PubMed ID: 35939971
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.
De Francesco MA; Baronio M; Fiorentini S; Signorini C; Bonfanti C; Poiesi C; Popovic M; Grassi M; Garrafa E; Bozzo L; Lewis GK; Licenziati S; Gallo RC; Caruso A
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9972-7. PubMed ID: 12105273
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.
Giagulli C; Magiera AK; Bugatti A; Caccuri F; Marsico S; Rusnati M; Vermi W; Fiorentini S; Caruso A
Blood; 2012 Mar; 119(10):2274-83. PubMed ID: 22262769
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.
Basta D; Latinovic O; Lafferty MK; Sun L; Bryant J; Lu W; Caccuri F; Caruso A; Gallo R; Garzino-Demo A
Pathog Dis; 2015 Nov; 73(8):ftv062. PubMed ID: 26333571
[TBL] [Abstract][Full Text] [Related]
20. CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
Lu Y; Wu Y; Feng X; Shen R; Wang JH; Fallahi M; Li W; Yang C; Hankey W; Zhao W; Ganju RK; Li MO; Cleveland JL; Zou X
J Clin Invest; 2014 Apr; 124(4):1672-84. PubMed ID: 24614102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
